Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2023 | YoY |
|---|---|---|
| Revenue | 48.52m | 11.69% |
| Gross profit | 9.86m | 31.95% |
| Net profit | -11.96m | 38.09% |
| EBITDA | -711.65k | 92.19% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €2.71m |
Number of shares | 402.58m |
52-week high/low | €0.0227 - €0.00615 |
| Dividends | No |
Beta | 1.13 |
P/E ratio | -0.05 |
PEG ratio | 0.00 |
P/B ratio | -0.12 |
P/S ratio | 0.02 |
Company profile
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. As of April 20, 2022, the company owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.
| Name | Delta 9 Cannabis |
| CEO | John William Arbuthnot IV |
| Headquarters | Winnipeg,
mb Canada |
| Website | |
| Sector | Consumer Staples |
| Industry | Tobacco |
| IPO | 06/11/2017 |
| Employees | 200 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | DLTNF |
Toronto Stock Exchange | DN.TO |
Frankfurt | V5D1.F |
München | V5D1.MU |
